Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer
- PMID: 15386786
- DOI: 10.1002/pon.821
Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer
Abstract
Women treated for breast cancer have shown cognitive deficits with reduced capacity to focus and concentrate or to direct attention. This study examined the relationship between cognitive function prior to any treatment for breast cancer and individual factors including age, education, menopausal status, chronic health problems, and distress. Women newly diagnosed with breast cancer (N=184), ages 27-86 years, were assessed with standardized attention tests, self-reports of effectiveness in cognitive functioning, and measures of distress at about 18 days before surgery. Measured performance on the cognitive tests was not significantly correlated to self-reports of effectiveness in cognitive functioning. Age, education, presence of a chronic health problem, and menopausal status, but not distress, were associated with performance on the cognitive tests. Only age and education, however, were significant (p<0.001) predictors of overall performance on the cognitive tests, when controlling covariates. In contrast, symptom and mood distress significantly (p<0.001) predicted perceptions of effectiveness in cognitive functioning. Thus, different factors were associated with measured performance versus self-reports of cognitive functioning. Individual factors that predispose to lowered effectiveness in cognitive functioning prior to treatment in women newly diagnosed with breast cancer are discussed.
2004 John Wiley & Sons, Ltd.
Similar articles
-
Anxiety and directed attention in women awaiting breast cancer surgery.Oncol Nurs Forum. 1999 May;26(4):767-72. Oncol Nurs Forum. 1999. PMID: 10337654
-
Predictors of cognitive decline after chemotherapy in breast cancer patients.J Int Neuropsychol Soc. 2009 Nov;15(6):951-62. doi: 10.1017/S1355617709990567. Epub 2009 Aug 27. J Int Neuropsychol Soc. 2009. PMID: 19709455
-
Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.J Med Assoc Thai. 2007 Oct;90(10):2164-74. J Med Assoc Thai. 2007. PMID: 18041438
-
[Cognitive impairments and breast cancer: a critical review of the literature].Bull Cancer. 2009 Feb;96(2):239-48. doi: 10.1684/bdc.2008.0818. Bull Cancer. 2009. PMID: 19258230 Review. French.
-
Cancer, cognitive impairment, and meditation.Acta Oncol. 2009;48(1):18-26. doi: 10.1080/02841860802415535. Acta Oncol. 2009. PMID: 19031161 Review.
Cited by
-
Oncology Outpatients With Worse Anxiety and Sleep Disturbance Profiles Are at Increased Risk for a Higher Symptom Burden and Poorer Quality of Life.Cancer Nurs. 2023 Nov-Dec 01;46(6):417-431. doi: 10.1097/NCC.0000000000001139. Epub 2022 Dec 1. Cancer Nurs. 2023. PMID: 35688433 Free PMC article.
-
Proposed mechanisms for cancer- and treatment-related cognitive changes.Semin Oncol Nurs. 2013 Nov;29(4):260-9. doi: 10.1016/j.soncn.2013.08.006. Semin Oncol Nurs. 2013. PMID: 24183157 Free PMC article. Review.
-
Changes in Attentional Function in Patients From Before Through 12 Months After Breast Cancer Surgery.J Pain Symptom Manage. 2020 Jun;59(6):1172-1185. doi: 10.1016/j.jpainsymman.2020.01.001. Epub 2020 Jan 15. J Pain Symptom Manage. 2020. PMID: 31953207 Free PMC article.
-
Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?J Clin Oncol. 2018 Aug 20;36(24):2483-2491. doi: 10.1200/JCO.2017.73.3592. Epub 2018 Jul 9. J Clin Oncol. 2018. PMID: 29985748 Free PMC article.
-
Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.Menopause. 2007 Nov-Dec;14(6):995-8. doi: 10.1097/gme.0b013e318148b28b. Menopause. 2007. PMID: 17898668 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical